{
    "Trade/Device Name(s)": [
        "ImmunoCAP Specific IgE"
    ],
    "Submitter Information": "Phadia AB",
    "510(k) Number": "K151029",
    "Predicate Device Reference 510(k) Number(s)": [
        "K113841",
        "K051218"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DHB"
    ],
    "Summary Letter Date": "December 21, 2015",
    "Summary Letter Received Date": "December 22, 2015",
    "Submission Date": "October 29, 2015",
    "Regulation Number(s)": [
        "21 CFR 866.5750"
    ],
    "Regulation Name(s)": [
        "Radioallergosorbent (RAST) immunological test system"
    ],
    "Analyte Class(es)": [
        "allergy",
        "immunology"
    ],
    "Analyte(s)": [
        "Allergen specific IgE antibodies"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Na-Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Phadia 100",
        "Phadia 250",
        "Phadia 1000",
        "Phadia 2500",
        "Phadia 5000"
    ],
    "Method(s)/Technology(ies)": [
        "Automated quantitative immunoassay"
    ],
    "Methodologies": [
        "Measurement of allergen specific IgE"
    ],
    "Submission Type(s)": [
        "Assay",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for ImmunoCAP Specific IgE automated quantitative assay and Phadia Prime laboratory software for detection of allergen specific IgE antibodies",
    "Indications for Use Summary": "In vitro quantitative assay for measurement of allergen specific IgE in human serum or plasma as an aid in diagnosing IgE-mediated allergic disorders, used with Phadia instruments in clinical laboratories",
    "fda_folder": "Immunology"
}